Cytokine Multiplex Assay Kits allow researchers to simultaneously detect the levels of multiple cytokines in a single sample. This is particularly useful for identifying the wide array of changes that can be associated with different pathological conditions. For multianalyte cytokine detection, we offer membrane-based Proteome Profiler Cytokine Antibody Arrays, bead-based Luminex® Assays, and Simple Plex automated ELISAs. For our antibody arrays, we offer human, mouse, or rat XL Cytokine Antibody Arrays that detect 105, 111, or 79 analytes respectively, including interleukins, interferons, chemokines, and members of the tumor necrosis factor superfamily. Our standard Luminex Assays for human, mouse, rat, porcine, and non-human primate (NHP) may also be used to detect many of these same analytes. With a menu of more than 490 analytes to select from, multiplexing with our Luminex assays provides the ability to simultaneously assess up to 50 analytes using magnetic microparticles. Experience consistent biomarker detection and ultra-sensitive results in less than 90 minutes with Ella, our automated benchtop ELISA. Simple Plex offers an extensive selection of over 250 fully validated assays essential to complete your cytokine research. Whether you want a stocked panel, ready to ship in just 2 days, a custom panel with up to 8 assays specific to your research, or a single assay cartridge for up to 72 samples ran simultaneously, Simple Plex has the solution to your research needs.
Neurodegeneration Early Progression Monitoring Panel
R&D Systems, part of Bio-Techne | Catalog # SPCKE-PS-010769
Simple Plex 32x6 panel containing IL-10 2nd Gen, IL-2, IFN-gamma 3rd Gen, TNF-alpha 2nd Gen, IL-8/CXCL8, and IL-6 3rd Gen with sample diluent SD13, and wash buffer. Sample type indicated with PS (Plasma/Serum).
Key Product Details
Features
The Simple Plex Human Multianalyte Assay is for the detection of human IFNg 3rd gen, IL-10 2nd gen, IL-2, IL-6 3rd gen, IL-8, and TNF-a 2nd gen in serum and plasma (EDTA/Heparin).
| Sample Type & Volume Required Per Well | Serum (25 uL), EDTA Plasma (25 uL), Heparin Plasma (25 uL) |
| Sensitivity | IFNg 3rd gen 0.17 pg/mL; IL-10 2nd gen 0.17pg/mL; IL-2 0.54 pg/mL; IL-6 3rd gen 0.11 pg/mL; IL-8 0.19 pg/mL; TNF-a 2nd gen 0.3 pg/mL |
| Assay Range | IFNg 3rd gen 0.17 - 4,000 pg/mL; IL-10 2nd gen 0.38 - 1,446 pg/mL; IL-2 0.54 - 2,050 pg/mL; IL-6 3rd gen 0.28 - 2,652pg/mL; IL-8 0.19 - 1,804 pg/mL; TNF-a 2nd gen 0.3 - 1,160 pg/mL |
Species
Human
Product Summary for Neurodegeneration Early Progression Monitoring Panel
Product Specifications
| Reactivity | Human |
| Specificity | Natural and recombinant human IFNg 3rd gen, IL-10 2nd gen, IL-2, IL-6 3rd gen, IL-8, TNF-a 2nd gen. |
| Cross-reactivity | <0.5% cross-reactivity observed with available related molecules. <50% cross-species reactivity observed with species tested. |
| Interference | No significant interference observed with available related molecules. |
Precision
Intra-Assay Precision (Precision within an assay) Each control was tested 16 times in one assay
Inter-Assay Precision (Precision between assays) Replicates of each control were tested in multiple assays performed by at least three technicians using two lots of reagent
| Intra-Assay Precision | Inter-Assay Precision | ||||
|---|---|---|---|---|---|
| Sample | 1 | 2 | 1 | 2 | |
| IFN-gamma 3rd gen | n | 16 | 16 | 16 | 16 |
| Mean (pg/mL) | 21.1 | 1175 | 23.4 | 1192 | |
| Standard Deviation | 1.48 | 33.4 | 2.52 | 99.4 | |
| CV (%) | 7 | 2.8 | 10.8 | 8.3 | |
| IL-10 2nd gen | n | 16 | 16 | 35 | 37 |
| Mean (pg/mL) | 8.89 | 462 | 10.8 | 477 | |
| Standard Deviation | 0.193 | 16.0 | 0.940 | 24.5 | |
| CV (%) | 2.2 | 3.5 | 8.7 | 5.1 | |
| IL-2 | n | 16 | 16 | 16 | 16 |
| Mean (pg/mL) | 15 | 648 | 13 | 608 | |
| Standard Deviation | 0.8 | 32.7 | 1.13 | 34 | |
| CV (%) | 5.3 | 5.1 | 8.7 | 5.6 | |
| IL-6 3rd gen | n | 16 | 16 | 40 | 40 |
| Mean (pg/mL) | 23.1 | 876 | 23.6 | 1008 | |
| Standard Deviation | 0.899 | 72.1 | 1.82 | 77.7 | |
| CV (%) | 3.9 | 8.2 | 7.7 | 7.7 | |
| IL-8 | n | 16 | 16 | 16 | 16 |
| Mean (pg/mL) | 28.7 | 1362 | 27.3 | 1463 | |
| Standard Deviation | 1.41 | 89.8 | 1.41 | 125 | |
| CV (%) | 4.9 | 6.6 | 5.2 | 8.6 | |
| TNF alpha 2nd Gen | n | 16 | 16 | 16 | 16 |
| Mean (pg/mL) | 6.99 | 383 | 0.662 | 36.9 | |
| Standard Deviation | 0.345 | 20.6 | 7.81 | 408 | |
| CV (%) | 4.9 | 5.4 | 8.5 | 9 | |
Recovery
Recovery at three different spiked concentrations within the range of the assay was evaluated.
| Sample Type | Average % Recovery | Range % | |
|---|---|---|---|
| IFN-gamma | EDTA Plasma (n=4) | 89 | 88-90 |
| Heparin Plasma (n=4) | 90 | 83-99 | |
| Serum (n=4) | 95 | 83-102 | |
| IL-10 2nd gen | EDTA Plasma (n=4) | 91 | 84-93 |
| Heparin Plasma (n=4) | 91 | 79-95 | |
| CCM (n=2) | 101 | 100-103 | |
| Serum (n=4) | 95 | 93-97 | |
| IL-2 | EDTA Plasma (n=4) | 86 | 69-100 |
| Heparin Plasma (n=4) | 90 | 70-103 | |
| Serum (n=4) | 92 | 69-102 | |
| IL-6 3rd gen | EDTA Plasma (n=4) | 92 | 86-102 |
| Heparin Plasma (n=4) | 87 | 85-90 | |
| CCM (n=2) | 104 | 103-106 | |
| Saliva (n=4) | 102 | 102-102 | |
| Urine (n=4) | 98 | 93-104 | |
| Serum (n=4) | 94 | 90-99 | |
| IL-8 | EDTA Plasma (n=5) | 89 | 75-102 |
| Heparin Plasma (n=5) | 95 | 88-102 | |
| Serum (n=3) | 92 | 88-97 | |
| TNF alpha 2nd Gen | EDTA Plasma (n=4) | 97 | 89-105 |
| Heparin Plasma (n=4) | 89 | 77-96 | |
| Serum (n=4) | 99 | 92-108 |
Formulation, Preparation, and Storage
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Background: Multiplex Cytokine Assay Kits
Additional Multiplex Cytokine Assay Kits Products
Product Documents for Neurodegeneration Early Progression Monitoring Panel
Loading product document information...
Product Specific Notices for Neurodegeneration Early Progression Monitoring Panel
For research use only
Loading...
Loading...
Loading...